Omada Health, Inc. Common Stock
Omada Health, Inc. provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various beh… Read more
Omada Health, Inc. Common Stock (OMDA) - Net Assets
Latest net assets as of September 2025: $217.35 Million USD
Based on the latest financial reports, Omada Health, Inc. Common Stock (OMDA) has net assets worth $217.35 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($287.47 Million) and total liabilities ($70.12 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $217.35 Million |
| % of Total Assets | 75.61% |
| Annual Growth Rate | -35.53% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 0.88 |
Omada Health, Inc. Common Stock - Net Assets Trend (2022–2024)
This chart illustrates how Omada Health, Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Omada Health, Inc. Common Stock (2022–2024)
The table below shows the annual net assets of Omada Health, Inc. Common Stock from 2022 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $64.63 Million | -34.66% |
| 2023-12-31 | $98.92 Million | -36.43% |
| 2022-12-31 | $155.60 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Omada Health, Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 11464800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $8.00K | 0.01% |
| Other Components | $508.59 Million | 786.91% |
| Total Equity | $64.63 Million | 100.00% |
Omada Health, Inc. Common Stock Competitors by Market Cap
The table below lists competitors of Omada Health, Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Neo Technical System Co. Ltd
KQ:085910
|
$80.50 Million |
|
Nivika Fastigheter AB Series B
ST:NIVI-B
|
$80.50 Million |
|
Quantafuel ASA
PINK:QNTFF
|
$80.52 Million |
|
Tatry Mountain Resorts a.s.
PR:TMR
|
$80.55 Million |
|
Outbrain Inc
NASDAQ:OB
|
$80.45 Million |
|
Comet Ridge Ltd
AU:COI
|
$80.43 Million |
|
Unitika Ltd
PINK:UNIKF
|
$80.41 Million |
|
Visiomed Group SA
PINK:VMDGF
|
$80.39 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Omada Health, Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 98,922,000 to 64,631,000, a change of -34,291,000 (-34.7%).
- Net loss of 47,137,000 reduced equity.
- New share issuances of 3,329,000 increased equity.
- Other factors increased equity by 9,517,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-47.14 Million | -72.93% |
| Share Issuances | $3.33 Million | +5.15% |
| Other Changes | $9.52 Million | +14.73% |
| Total Change | $- | -34.66% |
Book Value vs Market Value Analysis
This analysis compares Omada Health, Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 12.77x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 5.30x to 12.77x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-12-31 | $2.79 | $14.80 | x |
| 2023-12-31 | $1.77 | $14.80 | x |
| 2024-12-31 | $1.16 | $14.80 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Omada Health, Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -72.93%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -27.76%
- • Asset Turnover: 1.13x
- • Equity Multiplier: 2.33x
- Recent ROE (-72.93%) is below the historical average (-62.59%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | -46.60% | -81.31% | 0.40x | 1.43x | $-88.08 Million |
| 2023 | -68.25% | -54.98% | 0.70x | 1.77x | $-77.40 Million |
| 2024 | -72.93% | -27.76% | 1.13x | 2.33x | $-53.60 Million |
Industry Comparison
This section compares Omada Health, Inc. Common Stock's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $25,622,845
- Average return on equity (ROE) among peers: -162.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Omada Health, Inc. Common Stock (OMDA) | $217.35 Million | -46.60% | 0.32x | $80.49 Million |
| Accolade, Inc. (ACCD) | $390.85 Million | -12.96% | 0.22x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $80.90 Million | -180.10% | 1.78x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-6.40 Million | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-728.00K | 0.00% | 0.00x | $1.88 Million |
| Alternate Health Corp (AHGIF) | $1.36 Million | -129.15% | 0.71x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $-1.77 Million | 0.00% | 0.00x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $1.09 Million | -1305.34% | 0.76x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-71.11K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $-204.41 Million | 0.00% | 0.00x | $79.04 Million |